IMS Health's Siva Nadarajah and UCB's Greg Cohen talk about how to leverage technology, social analytics and listening tools to detect adverse events.
Via Pharma Guy
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
Experts urge pharma to focus on the customer, not the brand, when engaging in social media listening. This, they say, will deliver real value to pharma companies and their customers. But what exactly is the "real value" when the customer is the patient?
This was a question explored in a Pharma Marketing Talk podcast interview of Trish Nettleship, Director, Social Media & Influence, UCB, Inc., about her company's approach to social media listening. According to Nettleship, "active social media listening" helps her company understand patient needs and issues -- including adverse events -- and how this results in better communications and patient experiences."
This article summarizes that conversation.
Topics include:
- UCB's Approach
- Dealing with Adverse Events
- Become a Social Organization
- Current UCB Patient Communities
- Social Listening v. Focus Groups
- Branded v. Disease Conversations
- Budgetary Impact and ROI
- Online Patient Influencers
Download the full text PDF file here:www.pharma-mkting.com/news/pmnews1209-article01.pdf